Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Bonanno, Patricia Vella, Ermisch, Michael, Godman, Brian ORCID: 0000-0001-6539-6972, Martin, Antony P ORCID: 0000-0003-4383-6038, Van den Bergh, Jesper, Bezmelnitsyna, Liudmila, Bucsics, Anna, Arickx, Francis, Bybau, Alexander, Bochenek, Tomasz
et al (show 28 more authors) (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. FRONTIERS IN PHARMACOLOGY, 8 (AUG). 497-.


Godman, Brian ORCID: 0000-0001-6539-6972, Bucsics, Anna, Bonanno, Patricia Vella, Oortwijn, Wija, Rothe, Celia C, Ferrario, Alessandra, Bosselli, Simone, Hill, Andrew, Martin, Antony P ORCID: 0000-0003-4383-6038, Simoens, Steven
et al (show 42 more authors) (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. FRONTIERS IN PUBLIC HEALTH, 6 (DEC). 328-.


Malmström, Rickard E, Godman, Brian B ORCID: 0000-0001-6539-6972, Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Ferrario, Alessandra
et al (show 37 more authors) (2013) Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4 (39).


Ermisch, Michael, Bucsics, Anna, Bonanno, Patricia Vella, Arickx, Francis, Bybau, Alexander, Bochenek, Tomasz, van de Casteele, Marc, Diogene, Eduardo, Furst, Jurij, Garuoliene, Kristina
et al (show 21 more authors) (2016) Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways. FRONTIERS IN PHARMACOLOGY, 7 (SEP). 305-.


Godman, Brian ORCID: 0000-0001-6539-6972, Finlayson, Alexander E, Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Inaki ORCID: 0000-0002-4080-7963, Jones, Jan, Malmström, Rickard E, Asola, Elina, Baumgärtel, Christoph, Bennie, Marion
et al (show 35 more authors) (2013) Personalizing health care: feasibility and future implications. BMC medicine, 11 (1). 179-.


Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Selke Krulichová, Iva, Zampirolli Dias, Carolina, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Timoney, Angela, Gustafsson, Lars
et al (show 40 more authors) (2021) Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert review of pharmacoeconomics & outcomes research, 21 (4). pp. 527-540.


Bonanno, Patricia Vella, Bucsics, Anna, Simoens, Steven, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Gulbinovic, Jolanta, Rothe, Celia, Timoney, Angela, Ferrario, Alessandra, Gad, Mohamed
et al (show 26 more authors) (2019) Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19 (3). pp. 251-261.


Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovic, Jolanta
et al (show 13 more authors) (2020) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 18 (1). pp. 5-16.

This list was generated on Mon Oct 2 08:07:01 2023 BST.